798 patents currently held
90 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
147
Ending by 2030
Nov 2026
Next term end
463
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2029 · High confidence
Also notable
Ends Nov 2031 · Medium confidence
Also notable
Ends Oct 2027 · High confidence
Also notable
Ends Sep 2034 · High confidence
Also notable
Ends Oct 2036 · High confidence
Also notable
Ends Nov 2030 · High confidence
Also notable
Ends Mar 2029 · Medium confidence
Also notable
Ends Jul 2029 · High confidence
Stent Having Adjacent Elements Connected by Flexible Webs
US 8,926,688
Cited by 275 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Lattice
US 10,166,128
Cited by 97 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2031.
Expandable TFE copolymers, method of making, and porous, expended articles thereof
US 8,637,144
Cited by 145 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
External Steerable Fiber for Use in Endoluminal Deployment of Expandable Devices
US 9,782,282
Cited by 130 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Balloon Expandable Endoprosthesis
US 11,285,029
Cited by 20 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2036.
Expandable Functional TFE Copolymer Fine Powder, the Expandable Functional Products Obtained Therefrom and Reaction of the Expanded Products
US 9,139,669
Cited by 98 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Heart Occlusion Devices
US 10,278,705
Cited by 83 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Septal Closure Device with Centering Mechanism
US 9,005,242
Cited by 167 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Formerly held, still cited
Notable
Ends May 2031 · High confidence
Cited by 327 later US patents, top 1% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
now held by Endologix, LLC
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 23 to 26, 2026 · next Nov 23
- 3 fees due Dec 11 to 25, 2026 · next Dec 11
- 17 fees due Jan 2 to 30, 2027 · next Jan 2
- 15 fees due Feb 1 to 25, 2027 · next Feb 1
- 11 fees due Mar 1 to 26, 2027 · next Mar 1
- 15 fees due Apr 1 to 30, 2027 · next Apr 1
- 12 fees due May 3 to 28, 2027 · next May 3
- 16 fees due Jun 3 to 30, 2027 · next Jun 3
- 20 fees due Jul 2 to 30, 2027 · next Jul 2
- 15 fees due Aug 13 to 27, 2027 · next Aug 13
- 9 fees due Sep 1 to 26, 2027 · next Sep 1
- 12 fees due Oct 2 to 30, 2027 · next Oct 2
- 7 fees due Nov 3 to 19, 2027 · next Nov 3
Recent changes
- Nov 18Assignment recorded on 1 record: Minami, Kazuhiro to W. L. Gore & Associates G.K Recorded Nov 18, 2026, executed Nov 18, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76812, frame 450.
- Nov 6Assignment recorded on 1 record: Jensen, Cathryn to W. L. Gore & Associates, Inc. Recorded Nov 6, 2026, executed Oct 30, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76670, frame 583.
- 23 of the patents on this record were granted since Aug 23, 2026
- 10 terms have ended since Aug 23, 2026
- Nov 17 US 9,399,085 Immobilized Biologically Active Entities Containing Heparin Having High Biological Activity Following Mechanical Manipulation · term ended
- Nov 16 US 10,456,281 Stent Having Flexibly Connected Adjacent Stent Elements · term ended
- Oct 30 US 10,111,741 Intralumenal Stent Graft Fixation · lapsed on the fee record
- Oct 23 US 10,110,981 Vibro Acoustic Cover Using Expanded Ptfe Composite · lapsed on the fee record
- Oct 21 US 9,861,346 Patent foramen ovale (PFO) closure device with linearly elongating petals · term ended
- Oct 7 US 8,851,294 Aqueous Delivery System for Low Surface Energy Structures · lapsed on the fee record
- Oct 4 US 11,458,007 Devices and Methods for Limiting a Depth of Penetration for an Anchor within an Anatomy · lapsed on the fee record
- Sep 28 US 7,498,385 Polyester Compositions, Methods of Manufacturing Said Compositions, and Articles Made Therefrom · term ended
- Sep 22 US 9,622,770 Cerebral Vasculature Device · term ended
- Aug 28 US 10,058,442 Endoprosthesis Delivery System · lapsed on the fee record
What they patent
The largest of its 463 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,655,584 | Highly Porous Self-Cohered Web Materials In force · Medium confidence | In force | Medium confidence | |
| US 9,375,515 | Immobilized Biologically Active Entities Having High Biological Activity Following Mechanical Manipulation In force · High confidence | In force | High confidence | |
| US 7,753,945 | Deployment System for an Endoluminal Device In force · Medium confidence | In force | Medium confidence | |
| US 9,408,736 | Device for Deploying an Implantable Medical Device In force · High confidence | In force | High confidence | |
| US 8,029,563 | Implantable Devices with Reduced Needle Puncture Site Leakage In force · High confidence | In force | High confidence | |
| US 9,717,584 | Medical Apparatus and Method of Making the Same In force · High confidence | In force | High confidence | |
| US 8,267,988 | Side Branched Endoluminal Prostheses and Methods of Delivery Thereof In force · High confidence | In force | High confidence | |
| US 7,655,288 | Composite Self-Cohered Web Materials In force · Medium confidence | In force | Medium confidence | |
| US 7,630,749 | Implantable Electrophysiology Lead Body In force · High confidence | In force | High confidence | |
| US 7,927,363 | Device for Treating a Blood Vessel and Associated Treatment Kit In force · High confidence | In force | High confidence |
Also on record, not counted in the 798: 90 patents in force now held by others · 366 patents ended · 287 applications pending · 484 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.